December 28, 2014 2:32 AM ET

Pharmaceuticals

Company Overview of Oramed Pharmaceuticals Inc.

Company Overview

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. Its product portfolio includes ORMD-0801, an oral insulin capsule that completed Phase IIa clinical trials for the treatment of diabetes; and ORMD-0901, an analog for GLP-1 gastrointestinal hormone, which is in pre-clinical trials for the treatment of type 2 diabetes. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in Jerusalem, Israel.

Hi-Tech Park 2/4

Givat-Ram

PO Box 39098

Jerusalem,  91390

Israel

Founded in 2002

Phone:

972 2 566 0001

Fax:

972 2 566 0004

Key Executives for Oramed Pharmaceuticals Inc.

Chief Executive Officer
Age: 40
Total Annual Compensation: $381.3K
Chief Financial Officer
Age: 40
Total Annual Compensation: $193.8K
Chief Operating Officer and Vice President of Business Development
Age: 44
Total Annual Compensation: $199.2K
Chief Medical & Technology Officer and Director
Age: 74
Total Annual Compensation: $271.3K
Compensation as of Fiscal Year 2014.

Oramed Pharmaceuticals Inc. Key Developments

Oramed Pharmaceuticals Inc. Presents at LD Micro Conference, Dec-02-2014 05:00 PM

Oramed Pharmaceuticals Inc. Presents at LD Micro Conference, Dec-02-2014 05:00 PM. Venue: Luxe Sunset Boulevard Hotel, 11461 Sunset Boulevard, Los Angeles, California, United States. Speakers: Michael Berelowitz, Chairman of Scientific Advisory Board, Director and Member of Compensation Committee.

Oramed Pharmaceuticals Inc. Presents at FireRock Annual Micro-Cap Conference 2014, Oct-28-2014 09:15 AM

Oramed Pharmaceuticals Inc. Presents at FireRock Annual Micro-Cap Conference 2014, Oct-28-2014 09:15 AM. Venue: The Spring Mills Landmark Building, 104 W. 40th St, New York, New York, United States. Speakers: Nadav Kidron, Chief Executive Officer, President and Executive Director.

Oramed Pharmaceuticals Inc. - Special Call

To present detailed data from top-line clinical results from its Phase IIa clinical trial of ORMD-0801

Similar Private Companies By Industry

Company Name Region
Advanced Inhalation Technology Ltd. Middle East/Africa
AquaPro Technologies Ltd. Middle East/Africa
Pancrea-Tech Ltd Middle East/Africa
BioVent Ltd. Middle East/Africa
SUPHERB Middle East/Africa

Recent Private Companies Transactions

Type
Date
Target
Private Placement
November 3, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Oramed Pharmaceuticals Inc., please visit www.oramed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.